Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide
2013 | conference abstract. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide
Germing, U.; Giagounidis, A. A. N.; Buesche, G.; Platzbecker, U.; Goetze, K.; Nolte, F. & Schlenk, R. F. et al. (2013)
Leukemia Research, 37
Oxford: Pergamon-elsevier Science Ltd.
Documents & Media
Details
- Authors
- Germing, U.; Giagounidis, Aristoteles A. N.; Buesche, Guntram; Platzbecker, Uwe; Goetze, K.; Nolte, F.; Schlenk, Richard F.; Letsch, Anne; Ganser, Arnold; Luebbert, Michael; Bug, G.; Schafhausen, Philippe; Schemenau, J.; Haase, Detlef
- Issue Date
- 2013
- Status
- published
- Publisher
- Pergamon-elsevier Science Ltd
- Journal
- Leukemia Research
- ISSN
- 1873-5835; 0145-2126
- Extent
- S163
